0000000000458010

AUTHOR

Sergio Vigneri

showing 68 related works from this author

PPI-based triple therapy in the eradication of H. pylori infection.

1999

medicine.medical_specialtyGastrointestinal DiseasesGastroenterologyHelicobacter InfectionsPharmacotherapyInternal medicinemedicineHumansEnzyme InhibitorsOmeprazoleHepatologybiologyHelicobacter pyloribusiness.industryAnti-ulcer AgentGastroenterologyProton Pump InhibitorsHelicobacter pyloriH pylori infectionHelicobacter Infectionsbiology.organism_classificationAnti-Ulcer AgentsAnti-Bacterial AgentsDrug Therapy CombinationbusinessOmeprazolemedicine.drugGastroenterology
researchProduct

Variants of CARD15 are associated with an aggressive clinical course of Crohn's Disease. An IG-IBD Study

2005

Three major variants of the CARD15 gene confer susceptibility to Crohn's disease (CD). Whether or not these variants correlate with specific clinical features of the disease is under evaluation.We investigated the possible association of CARD15 variants with specific clinical characteristics, including the occurrence of anti-Saccharomyces cerevisiae antibodies (ASCA) and antineutrophil cytoplasmic antibodies (ANCA), in a large cohort of inflammatory bowel disease (IBD) patients and their unaffected relatives.Three hundred and sixteen CD patients (156 with positive family history), 408 ulcerative colitis (UC) patients (206 with positive family history), 588 unaffected relatives, and 205 unre…

AdultMaleNod2 Signaling Adaptor Proteindigestive systemCrohn DiseaseGene FrequencyHumansMedicineSettore MED/12 - GastroenterologiaCrohn's diseaseHepatologybiologyCrohn diseasebusiness.industryIntracellular Signaling Peptides and ProteinsGastroenterologyClinical courseMiddle Agedmedicine.diseasedigestive system diseasesPhenotypeItalyCase-Control StudiesMutationImmunologybiology.proteinColitis UlcerativeFemaleAntibodybusinessFollow-Up Studies
researchProduct

The Italian validation of the Montreal Global definition and classification of gastroesophageal reflux disease

2009

Recently, a Global definition and a classification of gastroesophageal reflux disease (GERD) were developed by Montreal Consensus Group, composed of international expert gastroenterologists. Guidelines and consensus documents are, however, infrequently accepted and adopted at a local level. The aim of this study was to measure the acceptance of Montreal Global definition of GERD consensus document by specialists in a single country (Italy) and to measure the linguistic, scientific, and practical differences between the international consensus document and the Italian version.A 2-day meeting was held in June 2007 in Rome, Italy, attended by 147 Italian physicians who were experts in gastroen…

Chest Painmedicine.medical_specialtyValidation studyEsophageal NeoplasmseducationMEDLINEDiseaseAdenocarcinomaGastroenterologyBarrett EsophagusTerminology as TopicInternal medicineHumansMedicineLanguageEvidence-Based MedicineHepatologybusiness.industryGastroenterologyRefluxSyndromeEvidence-based medicinemedicine.diseasedigestive system diseasesItalyEsophageal stenosisFamily medicinePractice Guidelines as TopicEsophageal StenosisGastroesophageal RefluxGERDbusinessPremalignant lesionEuropean Journal of Gastroenterology & Hepatology
researchProduct

Are morphology and composition of gallstones related? An x-ray diffraction study

1994

Abstract An x-ray diffractometric technique was used to study the crystalline composition of gallstones removed during surgery from 106 patients. Monohydrate cholesterol was found in the stones of 70 (66%) patients, either alone (33%) or in association with calcium salts (33%). The anhydrous form of cholesterol was found in the stones of 28 (26%) patients, either alone (10%) or in association with calcium salts (16%). These salts (vaterite, aragonite, and calcite) were found in 50% of cases in varying amounts (from 12% to 15% of the stone weight). Eight stones contained no cholesterol: 4 showed an amorphous pattern and 4 were composed of calcium carbonate salts. In 7 of 8 patients with bile…

PharmacologyCalcitemedicine.medical_specialtyBile ductbusiness.industryCholesterolAragoniteGallstonesengineering.materialGallbladder Stonemedicine.diseaseSurgerychemistry.chemical_compoundmedicine.anatomical_structureCalcium carbonatechemistryVateriteengineeringmedicinePharmacology (medical)businessNuclear chemistryCurrent Therapeutic Research
researchProduct

A case of bowel schistosomiasis not adhering to endoscopic findings

2005

Schistosomiasis is a chronic worm infection caused by a species of trematodes, the Schistosomes. We may distinguish a urinary form from Schistosomes haematobium and an intestinal-hepatosplenic form mainly from Schistosomes mansoni characterized by nausea, meteorism, abdominal pain, bloody diarrhea, rectal tenesmus, and hepatosplenomegaly. These infections represent a major health issue in Africa, Asia, and South America, but recently S mansoni has increased its prevalence in other continents, such as Europe countries and North America, due to international travelers and immigrants, with several diagnostic and prevention problems. We report a case of a 24-year-old patient without HIV infecti…

AdultMaleAbdominal painmedicine.medical_specialtySettore MED/09 - Medicina InternaHepatosplenomegalyColonoscopyCase ReportSchistosomiasisGastroenterologyPraziquantelFeceschemistry.chemical_compoundMesalazineIntestinal mucosaInternal medicineparasitic diseasesmedicineAnimalsHumansIntestinal MucosaParasite Egg CountSchistosomaAnthelminticsbiologymedicine.diagnostic_testGastroenterologybowel schistosomiasis; endoscopic findingsGeneral Medicinebiology.organism_classificationmedicine.diseaseRectal tenesmusSchistosomiasis mansonichemistryImmunologySchistosomamedicine.symptomWorld Journal of Gastroenterology
researchProduct

Psychometric validation of the Italian translation of the gastrointestinal symptom-rating scale and quality of life in reflux and dyspepsia questionn…

2007

Background: Symptoms of heartburn and their impact on health-related quality of life (HR-QOL) are often evaluated in clinical trials. When a questionnaire is translated into a new language, a linguistic validation is necessary but not sufficient unless the psychometric characteristics have been verified. Objective: To document the psychometric characteristics of the Italian translation of the Gastrointestinal Symptom-Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire. Patients and methods: 152 consecutive patients with symptoms of heartburn (mean ±SD age 46.5 ± 16.2 years; 40.1% males) completed the Italian translation of GSRS, the heartburn version of QO…

Abdominal painmedicine.medical_specialtyGASTROINTESTINAL SYMPTOM-RATING SCALEPSYCHOMETRIC VALIDATIONREFLUX AND DYSPEPSIAbusiness.industryRefluxHeartburnGeneral MedicineGERDLinguistic validationmedicine.diseaseIndigestionQuality of lifeQUALITY OF LIFERating scaleGERDPhysical therapyMedicinePharmacology (medical)medicine.symptombusiness
researchProduct

OAM for cure of Helicobacter pylori infection

2000

Helicobacter pylori infectionHepatologybusiness.industryGastroenterologyMedicinePharmacology (medical)businessVirologyAlimentary Pharmacology & Therapeutics
researchProduct

Comparison of isotope ratio mass spectrometry and nondispersive isotope-selective infrared spectroscopy for 13C-urea breath test.

1999

The 13C-urea breath test (UBT) is a sensitive and noninvasive method to diagnose Helicobacter pylori infection, but mass spectrometry (IRMS) is very expensive. The aims of this study were to compare the new low-priced infrared spectroscopy with IRMS in detecting the infection and to assess the influence of feeding on test accuracy.One hundred thirty-four patients with dyspeptic symptoms were recruited. Of these, 74 were infected and 60 uninfected on the basis of both CLO-test and histology. A subgroup of 37 patients (22 H. pylori-positive and 15 H. pylori-negative) was studied under fasting and nonfasting conditions on two different days. Duplicate breath samples were analyzed with two IRMS…

MalePathologymedicine.medical_specialtySpectrophotometry InfraredAnalytical chemistryInfrared spectroscopyMass spectrometrySensitivity and SpecificityMass Spectrometry13C urea breath testHelicobacter Infectionschemistry.chemical_compoundmedicineHumansUreaIsotope-ratio mass spectrometryDyspepsiaBreath testCarbon IsotopesHepatologymedicine.diagnostic_testIsotopeHelicobacter pyloribusiness.industryGastroenterologyMiddle AgedchemistryBreath TestsDuodenal UlcerUreaFemalebusiness
researchProduct

Negative Effect of Ranitidine on The Results of Urea Breath Test for The Diagnosis of Helicobacter Pylori

2001

In analogy with proton pump inhibitors, H2-antagonists may also be responsible for false-negative results on urea breath test for the detection of Helicobacter pylori. In this study we assessed the frequency and duration of false-negative urea breath tests in patients given different doses of ranitidine.A total of 120 consecutive dyspeptic patients infected with H. pylori on the basis of concomitant positive results of CLO-test, histology and urea breath test were recruited for this prospective, open, parallel-group study performed in an urban university gastroenterological clinic. They were randomized to receive an acute treatment with either ranitidine 300 mg once a day in the evening, ra…

Malemedicine.medical_specialtyTime FactorsUrea breath testSpirillaceaeRanitidineGastroenterologyHelicobacter InfectionsRanitidinechemistry.chemical_compoundInternal medicinemedicineHumansUreaProspective StudiesDyspepsiaFalse Negative ReactionsBreath testCarbon IsotopesDose-Response Relationship DrugHelicobacter pyloriHepatologymedicine.diagnostic_testbiologybusiness.industrydigestive oral and skin physiologyFalse Negative ReactionsGastroenterologyMiddle AgedHelicobacter pyloribacterial infections and mycosesHelicobacter Infectionsbiology.organism_classificationBreath TestsHistamine H2 AntagonistschemistryUreaFemalebusinessmedicine.drugAmerican Journal of Gastroenterology
researchProduct

Head-to-head comparison of 1-week triple regimens combining ranitidine or omeprazole with two antibiotics to eradicate Helicobacter pylori

1999

Background : Triple therapies containing omeprazole and ranitidine have been shown to be equivalent in eradicating H. pylori infection, but have been assessed either separately or head-to-head, only in small trials. Aim : To carry out a large randomized controlled study comparing omeprazole and ranitidine combined with two antibiotic combinations for 1 week. Methods : Three hundred and twenty H. pylori-positive patients were randomly subdivided into four equal-sized groups and received one of the following treatments: OAM = omeprazole 20 mg b.d. + amoxycillin 1 g b.d. + metronidazole 500 mg b.d.; RAM = ranitidine 300 mg b.d. + amoxycillin 1 g b.d. + metronidazole 500 mg b.d.; OAC = omeprazo…

medicine.medical_specialtyHepatologybiologymedicine.drug_classbusiness.industrySpirillaceaeAntibioticsGastroenterologyProton-pump inhibitorHelicobacter pyloribiology.organism_classificationGastroenterologySurgeryRanitidineClarithromycinInternal medicinemedicinePharmacology (medical)businessOmeprazolemedicine.drugAntibacterial agentAlimentary Pharmacology & Therapeutics
researchProduct

Optimal duration of therapy combining ranitidine bismuth citrate with clarithromycin and metronidazole in the eradication of Helicobacter pylori infe…

1999

Background: Ranitidine bismuth citrate (RBC) co-prescribed with clarithromycin and metronidazole for 1 week has been shown to be an effective eradicating regimen for Helicobacter pylori. Aim: To determine the optimal duration of this regimen. Methods: A series of 165 dyspeptic patients were recruited for this randomized, open, parallel-group study. They were subdivided into three groups receiving RBC 400 mg b.d. plus clarithromycin 250 mg b.d. and metronidazole 500 mg b.d. for three different periods (4, 7 and 10 days). H. pylori infection was assessed by the concomitant positivity of CLO-test and histology performed at the pre-entry endoscopy. The bacterium was considered eradicated on the…

Breath testmedicine.medical_specialtyIntention-to-treat analysisHepatologymedicine.diagnostic_testbiologybusiness.industryGastroenterologyHelicobacter pyloribiology.organism_classificationGastroenterologySurgeryRanitidineMetronidazoleRegimenInternal medicineClarithromycinmedicinePharmacology (medical)businessAntibacterial agentmedicine.drugAlimentary Pharmacology & Therapeutics
researchProduct

The 13C urea breath test in the diagnosis of Helicobacter pylori infection

1999

Summary The urea breath test (UBT) is one of the most important non-invasive methods for detecting Helicobacter pylori infection. The test exploits the hydrolysis of orally administered urea by the enzyme urease, which H pylori produces in large quantities. Urea is hydrolysed to ammonia and carbon dioxide, which diVuses into the blood and is excreted by the lungs. Isotopically labelled CO2 can be detected in breath using various methods. Labelling urea with 13 C is becoming increasingly popular because this non-radioactive isotope is innocuous and can be safely used in children and women of childbearing age. Breath samples can also be sent by post or courier to remote analysis centres. The …

Helicobacter pylori infectionmedicine.medical_specialtyUreaseUrea breath testGastroenterology13C urea breath testHelicobacter Infectionschemistry.chemical_compoundInternal medicineJournal ArticleMedicineIngestionHumansUreaCarbon RadioisotopesBreath testmedicine.diagnostic_testbiologyHelicobacter pyloribusiness.industryGastroenterologyHelicobacter pyloribiology.organism_classificationBiochemistrychemistryBreath Testsbiology.proteinUreabusiness
researchProduct

Oral manifestations in patients with gastro-oesophageal reflux disease: a single-center case-control study

2008

OBJECTIVE: To assess the occurrence of oral pathological changes and symptoms in patients affected by gastro-oesophageal reflux disease (GERD). PATIENTS AND METHODS: 200 patients with GERD and 100 matched healthy controls were studied. Thorough visual examination of the dental and oral mucosal tissues was performed and medical history relevant to oral symptoms was collected. The primary outcome was defined as a statistically significant difference, between the study group and controls, in the presence of the following indicators: soft/hard palate and uvula erythema, tooth wear, xerostomia, oral acid/burning sensation, subjective halitosis and dental sensitivity. Statistical analysis include…

Cancer ResearchUnivariate analysismedicine.medical_specialtyErythemabusiness.industryDentistryOdds ratioBurning mouth syndromemedicine.diseaseGastroenterologydigestive system diseasesPathology and Forensic Medicinestomatognathic diseasesstomatognathic systemOtorhinolaryngologyInternal medicineOral and maxillofacial pathologyGERDmedicinePeriodonticsMedical historyOral Surgerymedicine.symptombusinessEsophagitisJournal of Oral Pathology & Medicine
researchProduct

Stool antigen assay (HpSA) is less reliable than urea breath test for post-treatment diagnosis of Helicobacter pylori infection

2002

Summary Background : The diagnostic yield of the stool antigen test (HpSA) in evaluating the results of Helicobacter pylori eradication therapy is controversial, but many studies have used only the 13C-urea breath test (13C-UBT) as a gold standard which has greatly reduced their relevance. Aim : To compare the reliability of HpSA and 13C-UBT in patients post-treatment using biopsy-based methods as reference tests. Methods : A total of 100 consecutive dyspeptic patients (42 male and 58 female; mean age, 56 ± 18 years) were enrolled in our study. All patients were H. pylori positive on the basis of at least two biopsy-based methods, and underwent 1 week of treatment with various triple therap…

Breath testmedicine.medical_specialtyHepatologymedicine.diagnostic_testbiologybusiness.industryUrea breath testGastroenterologyRapid urease testGold standard (test)Helicobacter pyloribiology.organism_classificationGastroenterologySurgeryPredictive value of testsInternal medicineBiopsymedicinePharmacology (medical)businessAntibacterial agentAlimentary Pharmacology & Therapeutics
researchProduct

The characteristics of different diagnostic tests in adult mild asthmatic patients: Comparison with patients with asthma-like symptoms by gastro-oeso…

2007

SummaryBackgroundDiagnosing asthma cannot be always easy. It is important to consider the validity of the diagnostic tests, and/or how much more commonly they are positive in patients with asthma compared to healthy subjects and, particularly, to patients with asthma-like symptoms.ObjectiveTo evaluate the validity of diagnostic tests for asthma, in terms of sensitivity, specificity, positive and negative predictive values, in patients with bronchial asthma compared to patients affected by gastro-oesophageal reflux disease (GERD) with asthma-like symptoms, and healthy control subjects without asthma and gastro-oesophageal reflux (GER).DesignSingle-center, cross-sectional, observational study…

MaleVital capacitySettore MED/09 - Medicina Internaadult mild asthmatic patientVital CapacityGastroenterologygastro-oesophageal reflux.Bronchoconstrictor AgentsLeukocyte CountSensitivityimmune system diseasesForced Expiratory VolumeMethacholine ChlorideEosinophil cationic proteinRespiratory diseaseMiddle Agedrespiratory systemmedicine.anatomical_structureDiagnostic testsGastroesophageal RefluxSpecificityFemalemedicine.drugcirculatory and respiratory physiologyAdultPulmonary and Respiratory Medicinemedicine.medical_specialtyBronchial Provocation TestsDiagnosis DifferentialFEV1/FVC ratioGastro-oesophageal reflux diseaseInternal medicinemedicineHumansAsthmabusiness.industryEosinophil Cationic ProteinSputumadult mild asthmatic patients; gastro-oesophageal reflux.Eosinophilmedicine.diseaseAsthmaSurgeryrespiratory tract diseasesEosinophilsSpirometryGERDMethacholineEpidemiologic MethodsbusinessBiomarkersGastro-oesophageal refluxRespiratory Medicine
researchProduct

The stomach in liver cirrhosis

1991

Abstract The stomachs of cirrhotic patients are frequently subject to a number of alterations, detectable by endoscopy, the presence of which indicates a disturbance in the mucosa. Several investigators believe that portal hypertension plays an etiopathogenetic role. Three groups of subjects were studied prospectively: 83 cirrhotic patients with portal hypertension, 53 cirrhotic patients without portal hypertension, and 135 control subjects. Snake skin, scarlatina rash, and petechia were the most frequent endoscopic findings in the cirrhotic patients with portal hypertension ( P

medicine.medical_specialtyCirrhosisHepatologymedicine.diagnostic_testbusiness.industryEsophagogastroduodenoscopyStomachGastroenterologymedicine.diseaseControl subjectsGastroenterologyRashEndoscopymedicine.anatomical_structureInternal medicineMedicinePortal hypertensionmedicine.symptomPetechiabusinessGastroenterology
researchProduct

Clinical pharmacology and safety profile of esomeprazole, the first enantiomerically pure proton pump inhibitor

2001

Awareness of important differences in the pharmacological profile of individual optical isomers of chiral drugs led to the development of esomeprazole, the S-isomer of omeprazole, a new pharmacological entity designed to improve the clinical outcome of available proton pump inhibitors in the management of acid-related disorders. The superior acid control achieved by esomeprazole is mainly due to an advantageous metabolism compared with racemate omeprazole, leading to improved bioavailability and to enhanced delivery of the drug to the gastric proton pump.

DrugPeptic Ulcermedicine.drug_classmedia_common.quotation_subjectProton-pump inhibitorPharmacologyEsomeprazolelaw.inventionZollinger-Ellison SyndromelawmedicineHumansDrug InteractionsOmeprazoleRandomized Controlled Trials as Topicmedia_commonClinical pharmacologyHepatologybusiness.industryGastroenterologyEsomeprazoleProton Pump InhibitorsAnti-Ulcer AgentsBioavailabilityProton pumpSafety profilebusinessOmeprazolemedicine.drugDigestive and Liver Disease
researchProduct

Helicobacter pylori eradication in long-term users of non-steroidal anti-inflammatory drugs

1998

Non steroidal anti inflammatorybiologybusiness.industryImmunologyMedicineGeneral MedicineHelicobacter pyloribiology.organism_classificationbusinessThe Lancet
researchProduct

Comparable Helicobacter pylori eradication rates obtained with 4- and 7-day rabeprazole-based triple therapy: a preliminary study

2003

Abstract Background. Rabeprazole is a new proton pump inhibitor, which has been reported to induce a faster acid suppression than other drugs of the same category. This might be useful to reduce the duration of anti-Helicobacter therapies. Aims. The aim of this study was to assess whether there is the possibility of shortening a rabeprazole-based triple therapy from 7 to 4 days without compromising its efficacy in the eradication of Helicobacter pylori infection. Patients. A total of 128 consecutive dyspeptic patients with H. pylori infection were recruited for this controlled, randomized, open and parallel-group trial comparing the efficacy of two durations of the same rabeprazole-based tr…

MalePeptic Ulcermedicine.medical_specialtymedicine.drug_classUrea breath testRabeprazoleProton-pump inhibitorPilot ProjectsGastroenterology2-PyridinylmethylsulfinylbenzimidazolesDrug Administration ScheduleHelicobacter InfectionsAnti-Infective AgentsClarithromycinMetronidazoleClarithromycinInternal medicinemedicineHumansProspective StudiesDyspepsiaAdverse effectHelicobacter pyloriHepatologybiologymedicine.diagnostic_testbusiness.industryGastroenterologyProton Pump InhibitorsMiddle AgedHelicobacter pyloriAnti-Ulcer Agentsbiology.organism_classificationAnti-Bacterial AgentsMetronidazoleRegimenTreatment OutcomeRabeprazoleBenzimidazolesDrug Therapy CombinationFemalebusinessOmeprazolemedicine.drug
researchProduct

Improving opportunities for effective management of gastro-oesophageal reflux disease

2002

The recent introduction of proton pump inhibitors has extraordinarily improved the therapeutic approach to gastro-oesophageal reflux disease. The concept of decreasing gastric acid secretion and increasing the pH in the lower oesophagus has been demonstrated to be therapeutically effective and the higher the level of pH achieved, the better the results. In spite of the evident efficacy of these molecules, there are still many patients who will continue to have symptoms despite medical treatment. Proton pump inhibitors suppress gastric acidity, but this effect shows a remarkable interindividual variation depending on different reasons. Thus, it is still possible to optimise medical therapy f…

medicine.medical_specialtyBiological AvailabilityDiseaseGastroenterologyEsomeprazoleTherapeutic approachIsomerismInternal medicineEsophagitisHumansMedicineOmeprazoleHepatologybusiness.industrydigestive oral and skin physiologyGastroenterologyRefluxEsomeprazoleProton Pump InhibitorsHydrogen-Ion ConcentrationAnti-Ulcer Agentsdigestive system diseasesClinical trialTreatment OutcomeTolerabilityGastric MucosaGastroesophageal RefluxGastric acidbusinessOmeprazolemedicine.drugDigestive and Liver Disease
researchProduct

H2 antagonist and omeprazole nonresponders.

1991

Malemedicine.medical_specialtyPhysiologybusiness.industrymedicine.medical_treatmentGastroenterologyMiddle AgedHepatologyGastroenterologyH2 antagonistText miningTransplant surgeryHistamine H2 AntagonistsDuodenal UlcerInternal medicinemedicineHumansFemalebusinessOmeprazoleOmeprazolemedicine.drug
researchProduct

Evaluation of 24-hour gastric acidity in patients with hepatic cirrhosis.

1996

Data from previous studies on gastric acid secretion in patients with hepatic cirrhosis are controversial, due, at least in part, to the possible interference of liver failure and altered gastric mucosal microcirculation on the pharmacological action of the substances used to stimulate the parietal cell. For this reason, we wished to investigate the circadian pattern of gastric acidity by means of continuous 24-hour pH monitoring, which permits measurement of pH fluctuations in a nearly physiological manner and does not require any pharmacological stimulus.Forty-nine patients with liver cirrhosis of different aetiology were recruited for this study. They underwent 24-hour gastric pH-metry w…

AdultLiver CirrhosisMalemedicine.medical_specialtyCirrhosisGastroenterologyGastric AcidReference ValuesInternal medicinemedicineHumansCircadian rhythmProspective StudiesProspective cohort studyAntrumParietal cellAgedHepatologybiologybusiness.industryStomachdigestive oral and skin physiologyHelicobacter pyloriHydrogen-Ion ConcentrationMiddle Agedmedicine.diseasebiology.organism_classificationCircadian Rhythmmedicine.anatomical_structureGastric MucosaGastric acidFemalebusiness
researchProduct

Helicobacter pyloriinfection is not involved in the pathogenesis of either erosive or non-erosive gastro-oesophageal reflux disease

2003

Summary Background : The majority of reflux patients have non-erosive reflux disease. Aim : To evaluate the influence of Helicobacter pylori on oesophageal acid exposure in patients with both non-erosive and erosive reflux disease and in a group of controls. The pattern and distribution of chronic gastritis were also assessed. Methods : One hundred and twelve consecutive patients with symptoms of gastro-oesophageal reflux disease agreed to undergo both upper gastrointestinal endoscopy and 24-h oesophageal pH-metry. Patients were grouped as H. pylori-positive or H. pylori-negative on the basis of both CLO-test and histology, and as cases with or without oesophagitis on the basis of endoscopy…

medicine.medical_specialtyHepatologybiologyEsophageal diseasebusiness.industrySpirillaceaeGastroenterologyRefluxChronic gastritisHelicobacter pyloribiology.organism_classificationmedicine.diseaseGastroenterologymedicine.anatomical_structureInternal medicinemedicinePharmacology (medical)EsophagusGastritismedicine.symptombusinessAntrumAlimentary Pharmacology & Therapeutics
researchProduct

Association of Inflammation Markers with Impaired Insulin Sensitivity and Coagulative Activation in Obese Healthy Women

2003

Abstract Insulin resistance is associated with a low chronic inflammatory state. In this study we investigated the relationship between impaired insulin sensitivity and selected markers of inflammation and thrombin generation in obese healthy women. We examined 32 healthy obese women (body mass index ≥ 28), with normal insulin sensitivity (NIS, n = 14) or impaired insulin sensitivity (n = 18), and 10 nonobese women (body mass index < 25). Impaired insulin sensitivity patients had significantly higher levels of C-reactive protein (CRP), TGF-β1, plasminogen activator inhibitor-1 (PAI-1), activated factor VII (VIIa), and prothrombin fragment 1 + 2 (F1 + 2) compared with either control s…

Adultmedicine.medical_specialtyobesityEndocrinology Diabetes and Metabolismmedicine.medical_treatmentClinical BiochemistryPopulationInflammationFactor VIIaBiologyBiochemistryEndocrinologyInsulin resistanceTransforming Growth Factor betaInternal medicineinsulin resistancePlasminogen Activator Inhibitor 1medicineHumansProtein PrecursorseducationBlood CoagulationPancreatic hormoneeducation.field_of_studyInsulinBiochemistry (medical)ThrombinMiddle Agedmedicine.diseaseObesityPeptide FragmentsC-Reactive ProteinEndocrinologyhemostasis; inflammation; insulin resistance; obesityinflammationhemostasisFemaleProthrombinmedicine.symptomBody mass indexPlasminogen activatorBiomarkers
researchProduct

Efficacy of 1-week ranitidine-bismuth-citrate (RBC)-based triple therapy for eradication of Helicobacter pylori infection

1999

medicine.medical_specialtyHelicobacter pylori infectionRanitidineGastroenterologyHelicobacter InfectionsRanitidineMetronidazoleInternal medicineOrganometallic CompoundsmedicineHumansPharmacology (medical)Clinical Trials as TopicHelicobacter pyloriHepatologybiologybusiness.industryAnti-ulcer AgentGastroenterologyHelicobacter pyloriAnti-Ulcer AgentsHelicobacter Infectionsbiology.organism_classificationAnti-Bacterial AgentsMetronidazoleRanitidine HydrochlorideDrug Therapy CombinationAntacidsbusinessmedicine.drugAlimentary Pharmacology & Therapeutics
researchProduct

Absence of tolerance in duodenal ulcer patients treated for 28 days with a bedtime dose of roxatidine or ranitidine

1996

There is much experimental work on the occurrence of tolerance to the antisecretory effect of H2-receptor antagonists in healthy subjects, while data on its development in patients with duodenal ulcer are poor and conflicting. Moreover, this phenomenon has not been studied previously with 24 h gastric pH-metry in patients with active duodenal ulcer. For these reasons, we carried out a prospective pharmacodynamic investigation in 48 patients with endoscopically proven duodenal ulcer using the well-established once daily dosing schedule of H2 blockers. They were studied by means of 24 h continuous endoluminal pH-metry which was performed before, on d1 and d28 after receiving an oral bedtime d…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentRanitidineBedtimeGastroenterologyH2 antagonistRanitidinePiperidinesHistamine H2 receptorOral administrationDrug toleranceInternal medicinemedicineHumansSingle-Blind MethodPharmacology (medical)Prospective StudiesPharmacologyAnalysis of Variancebusiness.industryDrug ToleranceGastric Acidity DeterminationHydrogen-Ion ConcentrationMiddle Agedmedicine.anatomical_structureHistamine H2 AntagonistsDuodenal UlcerPharmacodynamicsDuodenumFemalebusinessmedicine.drugFundamental & Clinical Pharmacology
researchProduct

Endoscopic treatment of gastroesophageal reflux disease.

2005

Gastroesophageal reflux disease is a common chronic disorder which has a severe effect on the patient's quality of life. In view of the high cost of medical therapy and the limitations of surgery, a variety of endoscopic techniques have been developed for the treatment of this condition, and these have shown apparently encouraging results, at least in the short term. However, promising results have been obtained in only around two-thirds of patients over a short-term follow-up period of about 6 months. Moreover, several inconsistencies have emerged between the efficacy of this form of treatment in improving symptoms and quality of life and a lack of improvement of objective parameters, such…

medicine.medical_specialtyDiseaseEndoscopy GastrointestinalREFLUX DISEASE TREATMENTQuality of life (healthcare)medicineHumansPolymethyl MethacrylateIntensive care medicinemedicine.diagnostic_testEsophageal diseasebusiness.industrySuture TechniquesGastroenterologyRefluxmedicine.diseaseChronic disordersMicrospheresEndoscopySurgeryClinical trialCatheter AblationGastroesophageal RefluxPolyvinylsbusinessEndoscopic treatmentEndoscopy
researchProduct

Carditis in patients with gastro-oesophageal reflux disease: results of a controlled study based on both endoscopy and 24-h oesophageal pH monitoring

2004

Summary Background : There are conflicting reports on the role of gastro-oesophageal reflux disease (GERD) and Helicobacter pylori infection in the aetiology of carditis. Aim : The role of reflux and H. pylori infection in causing carditis was assessed in 113 consecutive patients with GERD and in 25 controls. Methods : All subjects underwent endoscopy and pH test and carditis was diagnosed on biopsies taken across the squamocolumnar junction. Helicobacter pylori was assessed by histology and rapid urease test. GERD was diagnosed by endoscopic oesophagitis or abnormal pH test. Results : Carditis was detected in 53 of 71 GERD patients and in 15 of 20 controls. Among patients, 18 showed absent…

medicine.medical_specialtyHepatologybiologybusiness.industryEsophageal diseaseGastroenterologyRefluxRapid urease testCarditisHelicobacter pylorimedicine.diseasebiology.organism_classificationGastroenterologydigestive system diseasesGastro-Internal medicinemedicineGERDEtiologyPharmacology (medical)businessAlimentary Pharmacology & Therapeutics
researchProduct

Management strategy for patients with gastroesophageal reflux disease: a comparison between empirical treatment with esomeprazole and endoscopy-orien…

2008

Management Strategy for Patients With Gastroesophageal Reflux Disease: A Comparison Between Empirical Treatment With Esomeprazole and Endoscopy-Oriented Treatment

medicine.medical_specialtyHepatologymedicine.diagnostic_testbusiness.industryEsophageal diseasemedicine.drug_classGastroenterologyRefluxProton-pump inhibitorDiseasemedicine.diseaseGastroenterologyEndoscopyEsomeprazolelaw.inventionQuality of lifeRandomized controlled triallawInternal medicinemedicinebusinessmedicine.drug
researchProduct

Enhanced Lipid Peroxidation and Platelet Activation in the Early Phase of Type 1 Diabetes Mellitus

2003

Background— To investigate early events possibly related to the development of diabetic angiopathy, we examined whether 8-iso-prostaglandin F 2α (8-iso-PGF 2α ) formation, a marker of in vivo oxidant stress, is altered in different stages of type 1 diabetes (T1DM) and whether it correlates with the rate of thromboxane (TX) A 2 biosynthesis, a marker of in vivo platelet activation. We also investigated the relationship between inflammatory markers and F 2 -isoprostane formation in this setting. Methods and Results— A cross-sectional study was performed in 23 insulin-treated patients aged <18 years with new-onset T1DM (≤6 weeks, group A), matched for age and gender with 23 patients with s…

diabetes mellitus; inflammation; plateletsMalemedicine.medical_specialtyAdolescentThromboxaneInflammationDiabetic angiopathyDinoprostTimeThromboxane A2Reference ValuesPhysiology (medical)Internal medicineDiabetes mellitusHumansInsulinMedicinePlatelet activationChildInterleukin 6InflammationF2-IsoprostanesType 1 diabetesbiologyInterleukin-6Tumor Necrosis Factor-alphabusiness.industryPlatelet Activationmedicine.diseaseThromboxane B2Oxidative StressC-Reactive ProteinCross-Sectional StudiesDiabetes Mellitus Type 1Endocrinologydiabetes mellitusplateletsDisease Progressionbiology.proteinFemaleTumor necrosis factor alphaLipid Peroxidationmedicine.symptomCardiology and Cardiovascular MedicinebusinessBiomarkersFollow-Up StudiesCirculation
researchProduct

Saliva variations in gastro-oesophageal reflux disease.

2007

Abstract Objectives The protective role of saliva in the case of oesophageal exposition to gastric acid has long been studied but some contradictions still remain. The main end-point of this study was to evaluate if a qualitative and quantitative alteration in salivary secretion exists in patients affected by GERD. Methods One hundred and twenty patients (T group) with clinically and endoscopically diagnosed GERD, and 98 healthy subjects (C group) have been evaluated; salivary tests (i.e. basal flow rate, stimulated flow rate, pH, [Na + ] and [K + ]) were performed, socio-demographical variables and oral GERD-related symptoms were taken into account. SPSS 10.5 software was used for statisti…

AdultMalemedicine.medical_specialtySalivaBurning Mouth SyndromeGastroenterologyXerostomiaStatistics NonparametricBasal (phylogenetics)Gastro-Internal medicinemedicineHumansSalivaGeneral DentistryAgedChi-Square Distributionbusiness.industryRefluxCase-control studyMiddle Agedmedicine.diseaseprotective role of salivahumanitiesdigestive system diseasesSurgeryCross-Sectional StudiesCase-Control StudiesGERDGastroesophageal RefluxGastric acidFemalebusinessSecretory RateChi-squared distributionJournal of dentistry
researchProduct

Comparison of the main oesophageal pathophysiological characteristics between short- and long-segment Barrett's oesophagus

2002

Aim: To assess the oesophageal manometric characteristics and 24-h pH profiles of patients with both short-segment and long-segment Barrett's oesophagus and compare them with those of patients with reflux oesophagitis and controls. Methods: Seventy-nine patients who had undergone upper digestive endoscopy were recruited: 16 had short-segment Barrett's oesophagus, 13 had long-segment Barrett's oesophagus, 25 had grade III oesophagitis according to the Savary–Miller classification and 25 were used as controls. The diagnosis of Barrett's oesophagus was based on the histological detection of specialized intestinal metaplasia, which extended  3 cm in patients with long-segment disease. All subje…

medicine.medical_specialtyHepatologybusiness.industryEsophageal diseasedigestive oral and skin physiologyGastroenterologyCase-control studyRefluxIntestinal metaplasiaLong segmentmedicine.diseasedigestive systemGastroenterologydigestive system diseasesPathophysiologymedicine.anatomical_structureInternal medicineotorhinolaryngologic diseasesmedicinePharmacology (medical)EsophagusbusinessEsophagitisAlimentary Pharmacology & Therapeutics
researchProduct

Helicobacter pylori and acid secretion

1998

Helicobacter pyloriHepatologybiologybusiness.industryGastroenterologyHelicobacter pyloribiology.organism_classificationHelicobacter InfectionsMicrobiologyGastric AcidDuodenal UlcerGastrinsHumansMedicineSecretionbusinessGastroenterology
researchProduct

A new 1-week therapy for Helicobacter pylori eradication: rani- tidine bismuth citrate plus two antibiotics

1997

Background: One-week triple regimens are currently the most recommended therapy for the eradication of Helicobacter pylori. No previous study has evaluated the efficacy of a short-term regimen combining ranitidine bismuth citrate with two antibiotics. Methods: Seventy-two consecutive H. pylori-positive dyspeptic patients were recruited for this randomized, three-centre, open, parallel-group study. They were subdivided into two groups receiving either ranitidine bismuth citrate 400 mg b.d. + clarithromycin 250 mg b.d. and metronidazole 500 mg b.d. (group A) or ranitidine bismuth citrate 400 mg b.d. + clarithromycin 250 mg b.d. and metronidazole 250 mg q.d.s (group B) for 1 week. H. pylori in…

Malemedicine.medical_specialtyRanitidineGastroenterologyGroup BHelicobacter InfectionsRanitidineClarithromycinMetronidazoleClarithromycinInternal medicinePyloric AntrummedicineHumansPharmacology (medical)Antibacterial agentHelicobacter pyloriHepatologybiologybusiness.industryGastroenterologyHelicobacter pyloribiology.organism_classificationAnti-Bacterial AgentsSurgeryMetronidazoleRegimenHistamine H2 AntagonistsRanitidine HydrochlorideDrug Therapy CombinationFemalebusinessBismuthmedicine.drugAlimentary Pharmacology and Therapeutics
researchProduct

The impact of antibiotic resistance on the efficacy of three 7-day regimens againstHelicobacter pylori

2000

Background: Antibiotic resistance affects the success of anti-Helicobacter pylori therapies and varies greatly from country to country. Aim: To compare the efficacy of three short-term triple regimens in relation to H. pylori primary resistance in our region. Methods: We enrolled 210 H. pylori-positive dyspeptic patients for this randomized, open, parallel-group study. Three arms of 70 patients each received the following 1-week regimens: (1) ranitidine bismuth citrate 400 mg b.d. + clarithromycin 250 mg b.d. + metronidazole 500 mg b.d. (RCM); (2) bismuth subcitrate 240 mg b.d. + amoxycillin 1000 mg b.d. + metronidazole 500 mg b.d. (BAM); (3) omeprazole 20 mg o.d. + clarithromycin 250 mg b.…

medicine.medical_specialtyHepatologybiologybusiness.industryGastroenterologyDrug resistanceHelicobacter pyloriAmoxicillinbiology.organism_classificationGastroenterologySurgeryMetronidazoleBismuth SubcitrateClarithromycinInternal medicinemedicinePharmacology (medical)businessOmeprazolemedicine.drugAntibacterial agentAlimentary Pharmacology & Therapeutics
researchProduct

The duodenum in liver cirrhosis: endoscopic, morphological and clinical findings.

1991

Endoscopic studies were performed to determine whether changes occurred in the duodenum related to portal hypertension in patients with liver cirrhosis. The total of 271 patients studied were subdivided into three groups: 83 patients with liver cirrhosis and portal hypertension, 53 with liver cirrhosis but no portal hypertension, and 135 controls. In the duodenum of cirrhotic patients with portal hypertension several changes were observed on endoscopy that were also present in the other two groups. Atrophy and vascular malformations, however, were present only in the duodenum of cirrhotic patients with portal hypertension, although in only a few patients and with statistical significance on…

Liver CirrhosisMalemedicine.medical_specialtyCirrhosisDuodenumGastroenterologyAtrophyEsophageal varicesDuodenitisInternal medicineHypertension PortalmedicineHumansEndoscopy Digestive SystemIntestinal MucosaAgedmedicine.diagnostic_testbusiness.industryGastroenterologyMiddle Agedmedicine.diseaseEndoscopymedicine.anatomical_structureDuodenumPortal hypertensionBlood VesselsFemaleComplicationbusinessEndoscopy
researchProduct

Effect of gastric acid suppression on 13 C-urea breath test: comparison of ranitidine with omeprazole

2000

Background: The assessment of the effect of H2 antagonists on the results of the urea breath test has produced controversial results. Aim: To assess whether standard doses of both omeprazole and H2 blockers can adversely influence the accuracy of the urea breath test. Methods: Sixty dyspeptic patients with ascertained Helicobacter pylori infection were recruited for this prospective, open study. They were randomized to receive either omeprazole 20 mg at 08:00 hours (n = 30) or ranitidine 300 mg at 22:00 hours (n = 30) for 14 days. The urea breath test was performed at baseline, on day 14, while patients were still taking the antisecretory drugs, and on day 21, 1 week after their cessation. …

Breath testmedicine.medical_specialtyHepatologybiologymedicine.diagnostic_testbusiness.industrymedicine.drug_classUrea breath testGastroenterologyProton-pump inhibitorHelicobacter pyloribiology.organism_classificationGastroenterologySurgeryRanitidineInternal medicineMedicineIngestionPharmacology (medical)businessAdverse effectOmeprazolemedicine.drugAlimentary Pharmacology & Therapeutics
researchProduct

Eradication of Helicobacter pylori in Recurrent Duodenal Ulcer

1993

medicine.medical_specialtybiologybusiness.industryInternal medicinemedicineGeneral MedicineHelicobacter pyloriRecurrent duodenal ulcerbiology.organism_classificationbusinessGastroenterologyNew England Journal of Medicine
researchProduct

Anti-helicobacter regimens

1996

Helicobacter pyloribiologybusiness.industryProton Pump InhibitorsGeneral Medicinebiology.organism_classificationAnti-Bacterial AgentsHelicobacter InfectionsHistamine H2 AntagonistsImmunologyHumansMedicineDrug Therapy CombinationHelicobacterbusinessThe Lancet
researchProduct

Circadian pattern of intragastric acidity in patients with non-erosive reflux disease (NERD)

2003

Summary Background : Most patients with gastro-oesophageal reflux disease have non-erosive reflux disease. Proton pump inhibitors are less effective than expected in these patients, but no previous study has measured their 24-h gastric pH values. Aims : To evaluate whether there are differences in 24-h intragastric acidity between reflux patients with and without oesophagitis and controls. The influence of Helicobacter pylori on the gastric pH of reflux patients was also assessed. Methods : Sixty-three consecutive patients with gastro-oesophageal reflux disease symptoms who agreed to undergo endoscopy and 24-h pH-metry were recruited. Twenty-five (39%) had erosive oesophagitis and 38 (61%) …

Breath testmedicine.medical_specialtyHepatologybiologymedicine.diagnostic_testbusiness.industryNerdEsophageal diseaseSpirillaceaeStomachdigestive oral and skin physiologyGastroenterologyRefluxHelicobacter pyloribiology.organism_classificationmedicine.diseaseGastroenterologydigestive system diseasesmedicine.anatomical_structureInternal medicinemedicinePharmacology (medical)businessEsophagitisAlimentary Pharmacology & Therapeutics
researchProduct

A Comparison of Five Maintenance Therapies for Reflux Esophagitis

1995

Patients with reflux esophagitis have a high rate of relapse within one year after therapy is discontinued.We enrolled 175 adults with endoscopy-confirmed reflux esophagitis in a prospective study comparing five maintenance therapies. All the patients were initially treated with omeprazole (40 mg orally once a day) for four to eight weeks, and healing was confirmed by endoscopy. Participants were then stratified according to their initial grade of esophagitis and randomly assigned to 12 months of treatment with one of the following: cisapride (10 mg three times a day), ranitidine (150 mg three times a day), omeprazole (20 mg per day), ranitidine plus cisapride (10 mg three times a day), or …

AdultMalemedicine.medical_specialtyRanitidineSeverity of Illness IndexGastroenterologyDisease-Free SurvivalRanitidinePiperidinesRecurrenceInternal medicinemedicineHumansSingle-Blind MethodProspective StudiesReflux esophagitisProspective cohort studyEsophagitis PepticOmeprazoleCisapridemedicine.diagnostic_testEsophageal diseasebusiness.industryGeneral MedicineMiddle AgedAnti-Ulcer Agentsmedicine.diseaseSurgeryEndoscopyTreatment OutcomeHistamine H2 AntagonistsCisaprideDrug Therapy CombinationFemaleEsophagoscopybusinessEsophagitisOmeprazolemedicine.drugNew England Journal of Medicine
researchProduct

Is Helicobacter pylori status relevant in the management of GORD?

2000

Summary There is growing interest in the relationship between H. pylori infection and gastro-oesophageal reflux disease (GORD). However, this relationship is complex, as yet not fully elucidated, and probably based on a multiplicity of factors. The prevalence of H. pylori infection in patients with GORD is similar, more often lower than in matched controls. There is a negative correlation between H. pylori infection and the severity of GORD. There are many hypothetical mechanisms by which H. pylori infection may protect from the development of GORD. Conversely, there are many possible mechanisms by which H. pylori infection could theoretically foster the GORD. Patients after H. pylori eradi…

medicine.medical_specialtyAtrophic gastritismedicine.drug_classProton-pump inhibitordigestive systemGastroenterologyInternal medicinemedicinePharmacology (medical)HelicobacterHepatologybiologybusiness.industryStomachdigestive oral and skin physiologyGastroenterologyIntestinal metaplasiaHelicobacter pylorimedicine.diseasebiology.organism_classificationdigestive system diseasesmedicine.anatomical_structureDysplasiaGastritismedicine.symptombusinessAlimentary Pharmacology & Therapeutics
researchProduct

A 10-day levofloxacin-based therapy in patients with resistant infection: A controlled trial

2004

Background & Aims: Antibiotic resistance is a major issue in anti– Helicobacter pylori treatment. This study was aimed at assessing the efficacy of 2 therapies in patients with resistant H pylori infection. Methods: Patients who had failed 1 or more eradication regimens underwent upper gastrointestinal endoscopy and 2 antral and 2 corpus biopsy specimens were taken for histology and culture. Metronidazole, clarithromycin, and amoxicillin resistance were determined by E-test. Patients were randomly assigned to 2 therapies: 1 group received pantoprazole 40 mg, amoxicillin 1 g, levofloxacin 250 mg, all twice daily for 10 days, and the other group was treated with omeprazole 20 mg twice daily f…

medicine.medical_specialtyHepatologybiologymedicine.diagnostic_testbusiness.industryUrea breath testGastroenterologyHelicobacter pyloriAmoxicillinbiology.organism_classificationGastroenterologySurgeryMetronidazoleLevofloxacinClarithromycinInternal medicinemedicinebusinessOmeprazolemedicine.drugPantoprazoleClinical Gastroenterology and Hepatology
researchProduct

Comparison of 24-h control of gastric acidity by three different dosages of pantoprazole in patients with duodenal ulcer

1998

Background It is now clear that the extent to which gastric acid secretion must be suppressed varies with the clinical condition being treated. Aim To assess the 24-h control of gastric acidity and the individual response variability of three different doses of pantoprazole. Methods Sixty-four duodenal ulcer patients were recruited for this prospective, randomized, multicentre, double-blind, parallel-group study. They were subdivided into three well-matched groups treated with 20 mg o.m., 40 mg o.m. and 40 mg b.d. of pantoprazole, respectively. Endoscopy and intragastric pH monitoring were performed in each patient before and after 14 days of treatment. Results Fifty-five patients were elig…

Gastric Acidity Determinationmedicine.medical_specialtyChemotherapyHepatologyDosebusiness.industrymedicine.drug_classStomachmedicine.medical_treatmentGastroenterologyProton-pump inhibitorGastroenterologymedicine.anatomical_structurePharmacodynamicsInternal medicinemedicineGastric acidPharmacology (medical)businessPantoprazolemedicine.drugAlimentary Pharmacology & Therapeutics
researchProduct

Potential options to optimize therapy of gastroesophageal reflux disease with proton pump inhibitors.

2007

Proton pump inhibitors (PPIs) are antisecretory agents that are widely used in the short- and long-term management of gastroesophageal reflux disease (GERD) to relieve symptoms, heal esophagitis, and prevent complications, such as strictures and Barrett’s esophagus. The total healthcare costs of GERD are high, especially for maintenance treatment. Therefore, the choice of cost-effective therapeutic options is an ineluctable challenge for public health authorities, third-party payers, and patients. In some European Union countries, a recent trend of public health authorities is to promote the choice of less expensive PPIs, regardless of their antisecretory potency – this in spite of the evid…

medicine.medical_specialtybusiness.industryGastroenterologyRefluxAntisecretory agentsEsomeprazoleProton Pump InhibitorsDiseaseProton pump inhibitorGastroesophageal reflux diseasemedicine.diseaseGastroenterologydigestive system diseasesInternal medicineGERDmedicineGastroesophageal RefluxHumansbusinessEsophagitisTherapy optimizationRandomized Controlled Trials as TopicDigestion
researchProduct

A temporary endoscopic solution that significantly improves the prognosis of Bouveret’s syndrome

1991

We report the case of a 73-year-old woman who was hospitalized for mild abdominal pain after her referral following a diagnostic assessment of acute lithiasic cholecystitis. After the spontaneus regression of her painful symptoms and fever and several days of well-being, her clinically acute abdominal features suddenly showed an obstruction of the upper gastrointestinal tract. An emergency esophagogastroduodenoscopy (EGDS) confirmed that a large gallstone completely obstructed the pylorus as previously demonstrated by an ultrasound examination of the gallbladder. During the course of endoscopy, removal of the gallstone from the duodenum was achieved by pulling it into the stomach; the patie…

medicine.medical_specialtyAbdominal painTime FactorsEndoscopy GastrointestinalPyloric StenosisPyloric stenosisCholelithiasisHumansMedicineAgedmedicine.diagnostic_testbusiness.industryEsophagogastroduodenoscopyGallbladderSyndromePrognosismedicine.diseasePylorusSurgeryEndoscopymedicine.anatomical_structureCholecystitisFemaleSurgerymedicine.symptombusinessAbdominal surgerySurgical Endoscopy
researchProduct

Acid and gastric metaplasia in the duodenum.

1994

Duodenal and antral mucosal biopsy specimens were obtained from 139 patients with dyspeptic complaints to study the prevalence and extent of gastric metaplasia in the duodenal bulb in relation to Helicobacter pylori (H pylori) infection and duodenal ulcer disease. On logistic regression, the presence and extent of gastric metaplasia was not significantly associated with H pylori infection. The prevalence of gastric metaplasia, however, was found to be higher in patients with current or past evidence of duodenal ulcer disease in comparison with subjects with functional dyspepsia (p = 0.01). A follow up study on 22 patients before and at least one year after eradication of H pylori showed tha…

Metaplasiamedicine.medical_specialtyPathologyHelicobacter pyloriDuodenumbusiness.industrydigestive oral and skin physiologyStomachGastroenterologyGastric MetaplasiaGastroenterologydigestive system diseasesHelicobacter InfectionsGastric Acidmedicine.anatomical_structureText miningInternal medicineDuodenumHumansMedicinebusinessResearch ArticleGut
researchProduct

Circadian gastric acidity in Helicobacter pylori positive ulcer patients with and without gastric metaplasia in the duodenum.

1996

BACKGROUND: The presence of gastric metaplasia allows helicobacter pylori to colonise the duodenum and this condition is thought to be acquired as a response to acid hypersecretion. This functional disorder, however, is present only in a subgroup of duodenal ulcer patients and, in addition, surface gastric metaplasia has been frequently found in the proximal duodenum of normal subjects and patients with non-ulcer dyspepsia, who cannot be certainly considered as acid hypersecretors. AIMS: To clarify the role of acid in inducing gastric type epithelium in the duodenum. This study aimed at assessing whether the pattern of circadian gastric acidity differs between H pylori positive duodenal ulc…

AdultMalemedicine.medical_specialtyDuodenumSpirillaceaeGastroenterologyEpitheliumHelicobacter InfectionsGastric AcidInternal medicineMetaplasiaBiopsymedicineHumansAntrumMonitoring PhysiologicAnalysis of VarianceMetaplasiabiologymedicine.diagnostic_testHelicobacter pyloribusiness.industrydigestive oral and skin physiologyStomachGastroenterologyHistologyHelicobacter pyloriHydrogen-Ion ConcentrationMiddle Agedbiology.organism_classificationdigestive system diseasesCircadian Rhythmmedicine.anatomical_structureGastric MucosaDuodenal UlcerDuodenumFemaleGastritismedicine.symptombusinessResearch Article
researchProduct

An evaluation of the antireflux properties of sodium alginate by means of combined multichannel intraluminal impedance and pH-metry.

2005

Summary Background : Alginate-based preparations act as mechanical antireflux barrier, which can reduce both acid and non-acid reflux events and limit the proximal migration of oesophageal refluxate. Aim : To evaluate all the above features with a novel technique, multichannel electrical impedance and pH-metry. Methods : Ten reflux patients underwent stationary impedancemetry and pH-metry after eating a refluxogenic meal. They were studied 1 h in basal conditions and 1 h after taking 10 mL of Gaviscon Advance. In both sessions, measurements were obtained in right lateral and supine decubitus. Results : Alginate preparation was able to decrease significantly (P < 0.05) the number of acid ref…

Novel techniqueAdultMalemedicine.medical_specialtySYMPTOMATIC TREATMENTACID REFLUXAlginatesSymptomatic treatmentSilicic AcidUrologySupine decubitusGASTROESOPHAGEAL-REFLUX DISEASEAluminum HydroxideGastric AcidPh metrymedicineHumansPharmacology (medical)Sodium alginateGASTROESOPHAGEAL-REFLUX DISEASE; SYMPTOMATIC TREATMENT; ACID REFLUXAgedHepatologybusiness.industrydigestive oral and skin physiologyGastroenterologyRefluxHydrogen-Ion ConcentrationMiddle Ageddigestive system diseasesSurgeryClinical PracticeDrug CombinationsSodium BicarbonateGastroesophageal RefluxDrug EvaluationFemaleAntacidsbusinessAlimentary pharmacologytherapeutics
researchProduct

The effects of omeprazole 20 and 40 mg twice daily on intragastric acidity in duodenal ulcer patients.

1996

BACKGROUND: The combination of omeprazole with amoxycillin or clarithromycin is used as treatment against Helicobacter pylori. It seems likely that the antibacterial activity of the antibiotic may be improved by increasing gastric pH towards neutrality, and a twice daily regimen of omeprazole is probably needed. AIM: To assess the effects of twice daily administration of omeprazole 20 and 40 mg. METHODS: Twelve duodenal ulcer patients in remission were randomized to receive in single-blind fashion either placebo, omeprazole 20 mg or omeprazole 40 mg twice daily (08.00 and 20.00 h). On the sixth day of dosing they underwent 24-h gastric pH-metry. RESULTS: Omeprazole 20 and 40 mg b.d. produce…

AdultMalemedicine.medical_specialtymedicine.drug_classProton-pump inhibitorGastroenterologyHelicobacter InfectionsGastric AcidInternal medicineClarithromycinmedicineHumansSingle-Blind MethodPharmacology (medical)Enzyme InhibitorsOmeprazoleGastric Acidity DeterminationCross-Over StudiesHelicobacter pyloriHepatologybiologybusiness.industryStomachGastroenterologyProton Pump InhibitorsGastric Acidity DeterminationMiddle AgedHelicobacter pyloribiology.organism_classificationCrossover studyCircadian Rhythmmedicine.anatomical_structureDuodenal UlcerDuodenumFemalebusinessOmeprazolemedicine.drugAlimentary Pharmacology &amp; Therapeutics
researchProduct

Helicobacter pylori eradication and reinfection

1995

biologybusiness.industryMedicineGeneral MedicineHelicobacter pyloribusinessbiology.organism_classificationVirologyThe Lancet
researchProduct

Optimal dose of omeprazole in duodenal ulcer

1993

Duodenal ulcermedicine.medical_specialtyHepatologybusiness.industryInternal medicineGastroenterologyMedicinebusinessGastroenterologyOmeprazolemedicine.drugEuropean Journal of Gastroenterology &amp; Hepatology
researchProduct

Terapia di mantenimento continuativa : limiti e vantaggi. In "Argomenti di Patologia Esofagea"

2004

researchProduct

Nomal values of 24-h ambulatory intraluminal combined with phmetry in subjects eating a mediterranean diet

2006

researchProduct

A 10-Day levofloxacin-Based Therapy in patients With resistant Helicobacter pylori Infection: A controlled Study

2004

researchProduct

Manifestazioni extradigestive ed atipiche della malattia da reflusso gastro-esofageo

2008

researchProduct

COULD SALIVA CHANGES PLAY A CASUAL ROLE IN GERD?A CASE CONTROL STUDY.

2006

researchProduct

Malattia da Reflusso Gastroesofageo ed esofagiti infettive.

2007

researchProduct

L'Esito della NERD.

2006

researchProduct

Oral manifestations in patients with gastro-oesophageal reflux disease: a single-center-case-control study

2008

Oral manifestations/ gastro-oesophageal reflux
researchProduct

La ricerca dell'appropriatezza Terapeutica nella malattia da reflusso gastroesofageo dopo vent'anni dalla introduzione degli inibitori di pompa proto…

2008

researchProduct

GERD in the elderly: an endoscopic experience.

2013

Settore MED/09 - Medicina InternaGERDelderlyGERD; elderly
researchProduct

Carditis in patients with gastro-oesophageal reflux disease: results of a controlled study based on both endoscopy and 24-h oesophageal pH monitoring.

2004

researchProduct

Terapia di mantenimento continuativa : limiti e vantaggi

2004

researchProduct

Esomeprazole-based regimens for Helicobacter pylori eradication

2004

researchProduct

Gastroesophageal reflux disease in the elderly: an update.

2013

Settore MED/09 - Medicina InternaGERD elderly
researchProduct

Burden of illness in Italian patients with gastro-oesophageal reflux disease.

2005

researchProduct

Patologia neoplastica dell'esofago

2004

researchProduct